TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/15/20 16:07 | 12/11/20 | ARNA | Arena Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Dallas Jayson Donald Alexander | CA | D | P | 0 | 69.31 | 0 | 0 | 0 | 7 | D | |||||||||||||||
12/9/20 16:03 | 12/8/20 | ARNA | Arena Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Dallas Jayson Donald Alexander | CA | D | P | 0 | 66.25 | 0 | 0 | 0 | 7 | D | |||||||||||||||
3/10/20 20:48 | 3/10/20 | AIMT | Aimmune Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dallas Jayson Donald Alexander | CA | DO | P,CEO | P | 50 | 18.74 | 0 | 3 | 2 | 123 | D | ||||||||||||||
11/19/18 20:12 | 11/19/18 | AIMT | Aimmune Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dallas Jayson Donald Alexander | CA | DO | P,CEO | P | 101 | 27.56 | 0 | 4 | 6 | 64 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |